(BHC) Bausch Health - Performance -7.9% in 12m
BHC performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-64.43%
#127 in Peer-Group
Rel. Strength
32.95%
#5101 in Stock-Universe
Total Return 12m
-7.94%
#99 in Peer-Group
Total Return 5y
-66.38%
#112 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 1.34 |
| High / Low | CAD |
|---|---|
| 52 Week High | 13.65 CAD |
| 52 Week Low | 6.01 CAD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 95.60 |
| Buy/Sell Signal +-5 | 3.04 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BHC (-7.9%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: BHC vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for BHC
| Total Return (including Dividends) | BHC | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 26.09% | 4.35% | 1.11% |
| 3 Months | -19.20% | -6.89% | 5.58% |
| 12 Months | -7.94% | -5.08% | 10.51% |
| 5 Years | -66.38% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | BHC | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 53.2% | 65.8% | 69.9% |
| 3 Months | -60.1% | -72% | 69.3% |
| 12 Months | -30.8% | -62.2% | 43.2% |
| 5 Years | -71.4% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #22 | 20.84% | 24.71% |
| 3 Month | #154 | -13.22% | -23.47% |
| 12 Month | #100 | -3.01% | -16.69% |
| 5 Years | #117 | -77.66% | -83.92% |
FAQs
Does Bausch Health (BHC) outperform the market?
No,
over the last 12 months BHC made -7.94%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months BHC made -19.20%, while XLV made -6.89%.
Performance Comparison BHC vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BHC vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 22.4% | 25% | -24.6% | -18% |
| US NASDAQ 100 | QQQ | 22.6% | 24.6% | -23.8% | -17% |
| German DAX 40 | DAX | 24.6% | 26.8% | -40.9% | -37% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 22.7% | 27% | -26.4% | -19% |
| Hongkong Hang Seng | HSI | 21.9% | 21% | -43.6% | -35% |
| India NIFTY 50 | INDA | 24.1% | 27.4% | -23.6% | -6% |
| Brasil Bovespa | EWZ | 20% | 25.6% | -44.8% | -17% |
BHC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 22.7% | 24.6% | -27.4% | -31% |
| Consumer Discretionary | XLY | 22.9% | 27.9% | -14.7% | -26% |
| Consumer Staples | XLP | 22.7% | 26.3% | -26.1% | -15% |
| Energy | XLE | 16.5% | 23.2% | -28.2% | -11% |
| Financial | XLF | 24% | 28.7% | -27.4% | -32% |
| Health Care | XLV | 20.4% | 21.7% | -24.1% | -3% |
| Industrial | XLI | 23.4% | 25.8% | -30.1% | -26% |
| Materials | XLB | 23% | 24.7% | -25.4% | -7% |
| Real Estate | XLRE | 21.9% | 25.1% | -25.6% | -21% |
| Technology | XLK | 22.1% | 24.1% | -25% | -12% |
| Utilities | XLU | 21% | 25.6% | -32.9% | -29% |
| Aerospace & Defense | XAR | 23.4% | 20.3% | -41.5% | -51% |
| Biotech | XBI | 22.7% | 18.3% | -13.8% | -0% |
| Homebuilder | XHB | 24% | 31.1% | -9.2% | 1% |
| Retail | XRT | 26.3% | 26.3% | -16.6% | -9% |
BHC vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.6% | 7.40% | -34.4% | -11% |
| Natural Gas | UNG | 23.1% | 28.7% | -42.9% | 7% |
| Gold | GLD | 18.8% | 19.9% | -54.7% | -55% |
| Silver | SLV | 23.2% | 14.7% | -44.2% | -30% |
| Copper | CPER | 24.9% | 24.4% | -39.5% | -16% |
BHC vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 20.9% | 25.4% | -23.1% | -4% |
| iShares High Yield Corp. Bond | HYG | 21.9% | 25.6% | -28.3% | -17% |